Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) can lead to serious complications such as coronary heart disease and hypertension due to oxidative stress. Sestrin2 expression is upregulated under conditions of oxidative stress. This study aimed to explore whether Sestrin2 was involved in OSA. OSA and healthy control...

Full description

Saved in:
Bibliographic Details
Main Authors: Rong Jiang, Qiru Wang, Huifen Zhai, Xiaohua Du, Shibo Sun, Haoyan Wang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2019/2047674
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560835839393792
author Rong Jiang
Qiru Wang
Huifen Zhai
Xiaohua Du
Shibo Sun
Haoyan Wang
author_facet Rong Jiang
Qiru Wang
Huifen Zhai
Xiaohua Du
Shibo Sun
Haoyan Wang
author_sort Rong Jiang
collection DOAJ
description Obstructive sleep apnea (OSA) can lead to serious complications such as coronary heart disease and hypertension due to oxidative stress. Sestrin2 expression is upregulated under conditions of oxidative stress. This study aimed to explore whether Sestrin2 was involved in OSA. OSA and healthy control subjects were recruited and matched with age, gender, and body mass index (BMI). Plasma Sestrin2 levels were measured and compared. A multivariate stepwise regression model was used to detect the relationship between Sestrin2 and other variable factors. The Sestrin2 levels were compared between before and after four weeks treatment by nasal continuous positive airway pressure (nCPAP) in severe OSA patients. Fifty-seven subjects were divided into two groups: control group (39.33 ± 9.40 years, n = 21) and OSA group (38.81 ± 7.84 years, n = 36). Plasma Sestrin2 levels increased in the OSA group (control group 2.06 ± 1.76 ng/mL, OSA group 4.16 ± 2.37 ng/mL; P=0.001). Sestrin2 levels decreased after four-week nCPAP treatment (pre-nCPAP 5.21 ± 2.32 ng/mL, post-nCPAP 4.01 ± 1.54 ng/mL; P=0.004). Sestrin2 was positively correlated with apnea/hypopnea index (AHI) oxygen desaturation index, while negatively correlated with mean oxygen saturation. Moreover, these correlations remained unchanged after adjusting for gender, age, waist-to-hip ratio, and body mass index. Multiple regression analysis showed that there was an association between Sestrin2 and AHI. Our findings suggest that Sestrin2 is involved in OSA. The increase of plasma Sestrin2 is directly related to the severity of OSA. To some extent, Sestrin2 may be useful for determining the severity of OSA and monitoring the effect of CPAP. In addition, since some complications of OSA such as coronary heart disease and diabetes are usually related with oxidative stress, the role of Sestrin2 in those OSA complications needs further study.
format Article
id doaj-art-d8f5cae13f65417ca5e66a2b5ffb6c6e
institution Kabale University
issn 1198-2241
1916-7245
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-d8f5cae13f65417ca5e66a2b5ffb6c6e2025-02-03T01:26:36ZengWileyCanadian Respiratory Journal1198-22411916-72452019-01-01201910.1155/2019/20476742047674Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep ApneaRong Jiang0Qiru Wang1Huifen Zhai2Xiaohua Du3Shibo Sun4Haoyan Wang5Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, ChinaDepartment of Respiratory Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaObstructive sleep apnea (OSA) can lead to serious complications such as coronary heart disease and hypertension due to oxidative stress. Sestrin2 expression is upregulated under conditions of oxidative stress. This study aimed to explore whether Sestrin2 was involved in OSA. OSA and healthy control subjects were recruited and matched with age, gender, and body mass index (BMI). Plasma Sestrin2 levels were measured and compared. A multivariate stepwise regression model was used to detect the relationship between Sestrin2 and other variable factors. The Sestrin2 levels were compared between before and after four weeks treatment by nasal continuous positive airway pressure (nCPAP) in severe OSA patients. Fifty-seven subjects were divided into two groups: control group (39.33 ± 9.40 years, n = 21) and OSA group (38.81 ± 7.84 years, n = 36). Plasma Sestrin2 levels increased in the OSA group (control group 2.06 ± 1.76 ng/mL, OSA group 4.16 ± 2.37 ng/mL; P=0.001). Sestrin2 levels decreased after four-week nCPAP treatment (pre-nCPAP 5.21 ± 2.32 ng/mL, post-nCPAP 4.01 ± 1.54 ng/mL; P=0.004). Sestrin2 was positively correlated with apnea/hypopnea index (AHI) oxygen desaturation index, while negatively correlated with mean oxygen saturation. Moreover, these correlations remained unchanged after adjusting for gender, age, waist-to-hip ratio, and body mass index. Multiple regression analysis showed that there was an association between Sestrin2 and AHI. Our findings suggest that Sestrin2 is involved in OSA. The increase of plasma Sestrin2 is directly related to the severity of OSA. To some extent, Sestrin2 may be useful for determining the severity of OSA and monitoring the effect of CPAP. In addition, since some complications of OSA such as coronary heart disease and diabetes are usually related with oxidative stress, the role of Sestrin2 in those OSA complications needs further study.http://dx.doi.org/10.1155/2019/2047674
spellingShingle Rong Jiang
Qiru Wang
Huifen Zhai
Xiaohua Du
Shibo Sun
Haoyan Wang
Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
Canadian Respiratory Journal
title Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
title_full Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
title_fullStr Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
title_full_unstemmed Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
title_short Explorating the Involvement of Plasma Sestrin2 in Obstructive Sleep Apnea
title_sort explorating the involvement of plasma sestrin2 in obstructive sleep apnea
url http://dx.doi.org/10.1155/2019/2047674
work_keys_str_mv AT rongjiang exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea
AT qiruwang exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea
AT huifenzhai exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea
AT xiaohuadu exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea
AT shibosun exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea
AT haoyanwang exploratingtheinvolvementofplasmasestrin2inobstructivesleepapnea